These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1652355)

  • 41. Evaluation of pre-irradiation on monoclonal antibody localization in colon tumor xenografts expressing a cell-associated antigen.
    Gridley DS; Slater JB; Slater JM
    Anticancer Res; 1995; 15(1):99-104. PubMed ID: 7733650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
    Wang ZF; Stein R; Sharkey RM; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioimmunodetection of implanted tumors with gamma probe.
    Hinkle GH; Abdel-Nabi H; Miller EA; Schlanger LE; Houchens DP; Thurston MO; Aitken DR; Mojzisik CM; Olsen JO; Tuttle SE
    NCI Monogr; 1987; (3):83-7. PubMed ID: 3821922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor intervention to reduce myelosuppression.
    Blumenthal RD; Sharkey RM; Goldenberg DM
    J Natl Cancer Inst; 1992 Mar; 84(6):399-407. PubMed ID: 1538418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
    Szalai G; Williams LE; Primus FJ
    Int J Cancer; 2000 Mar; 85(6):751-6. PubMed ID: 10709090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.
    Blumenthal RD; Sharkey RM; Kashi R; Goldenberg DM
    Int J Cancer; 1989 Aug; 44(2):292-300. PubMed ID: 2759735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
    Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
    Buchegger F; Vacca A; Carrel S; Schreyer M; Mach JP
    Int J Cancer; 1988 Jan; 41(1):127-34. PubMed ID: 3335416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
    Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
    Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.
    Garambois V; Glaussel F; Foulquier E; Ychou M; Pugnière M; Luo RX; Bezabeh B; Pèlegrin A
    BMC Cancer; 2004 Oct; 4():75. PubMed ID: 15488142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
    Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
    Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts.
    Lewis JC; Boxer GM; Searle F; Bagshawe KD
    Tumour Biol; 1984; 5(5):255-61. PubMed ID: 6397841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.
    Yazaki PJ; Kassa T; Cheung CW; Crow DM; Sherman MA; Bading JR; Anderson AL; Colcher D; Raubitschek A
    Nucl Med Biol; 2008 Feb; 35(2):151-8. PubMed ID: 18312824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
    J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability.
    Blumenthal RD; Kashi R; Sharkey RM; Goldenberg DM
    Int J Cancer; 1995 May; 61(4):557-66. PubMed ID: 7759161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An assessment of prolonged reactivity of seven monoclonal antibodies against CX-1 tumor xenografts using a hand-held gamma-detecting probe.
    Nieroda CA; Siddiqi MA; Hinkle GH; Hill TL; Mojzisik C; Olsen J; Rousseau M; Gersman M; Houchens DP; Sardi A
    J Invest Surg; 1989; 2(3):227-40. PubMed ID: 2487252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
    Behr TM; Sharkey RM; Sgouros G; Blumenthal RD; Dunn RM; Kolbert K; Griffiths GL; Siegel JA; Becker WS; Goldenberg DM
    Cancer; 1997 Dec; 80(12 Suppl):2591-610. PubMed ID: 9406714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.